Chair: Nikolas Haass
The genomic landscape of melanoma-prone skin (#102)
3:30 PM
Dissecting the roles of BAP1 in uveal melanoma (#103)
4:00 PM
BackTIL the Future: Cell Therapy for Immunotherapy Resistant Metastatic Melanoma (#104)
4:30 PM
Targeting Melanoma Heterogeneity to Improve both Targeted and Immune Therapy (#105)
5:00 PM